Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05524064 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax

Study acronym: FAST-02
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Primary and study completion dates: Apr 1, 2025 to May 1, 2027
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 1 to 2
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 1, 2022 to Mar 8, 2023
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to assess toxicities of FLASH radiotherapy treatment and pain relief in subjects with painful thoracic bone metastases. FLASH radiotherapy is radiation treatment delivered at ultra-high dose rates compared to conventional radiation treatment.
Trial Details
NCT Number NCT05524064
Lead Sponsor Varian, a Siemens Healthineers Company
Conditions
(from sponsor)		 Bone Metastases in the Thorax
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov